Literature DB >> 21401703

Advanced histology and impaired liver regeneration are associated with disease severity in acute-onset autoimmune hepatitis.

Keiichi Fujiwara1, Masayuki Nakano, Shin Yasui, Koichiro Okitsu, Yutaka Yonemitsu, Osamu Yokosuka.   

Abstract

AIMS: Some cases of acute-onset autoimmune hepatitis (AIH) develop into severe or fulminant forms showing massive/submassive hepatic necrosis, and have a poor prognosis. The pathological features of acute-onset AIH remain uncertain. Ductular (intermediate) hepatocytes after massive/submassive necrosis may serve as hepatic progenitor cells, and could be seen as cytokeratin 7 (CK7)-positive hepatocytes in immunohistochemistry. Therefore, the aim was to examine histological features to obtain a better evaluation of acute-onset AIH.
METHODS: The histological features of 27 clinically acute-onset AIH patients were examined by immunohistochemistry using CK7.
RESULTS: On staining for CK7, intermediate hepatocytes were less commonly present (P < 0.001) and ductular reactions were more commonly present (P < 0.001) in severe/fulminant patients than in non-severe ones. In severe and fulminant patients, intermediate hepatocytes and intralobular progenitor cells were more commonly present (P < 0.005 and P < 0.05, respectively) and ductular reactions were less commonly present (P = 0.007) in recovered patients than in dead ones. Severe patients had more clinically and histologically advanced disease.
CONCLUSIONS: Immunohistochemical evaluation using CK7 might be a useful tool for evaluating liver regeneration, and intermediate hepatocytes and progenitor cells might play an important role in liver regeneration after massive and submassive necrosis in acute-onset AIH.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21401703     DOI: 10.1111/j.1365-2559.2011.03790.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  8 in total

1.  Long-term observation of acute-onset autoimmune hepatitis presenting clinically and radiologically as acute hepatitis.

Authors:  Keiichi Fujiwara; Yoshihiro Fukuda; Katsushi Seza; Masaya Saito; Shin Yasui; Masayuki Nakano; Osamu Yokosuka; Naoya Kato
Journal:  Hepatol Int       Date:  2018-02-15       Impact factor: 6.047

2.  Efficacy of intravenous glycyrrhizin in the early stage of acute onset autoimmune hepatitis.

Authors:  Shin Yasui; Keiichi Fujiwara; Akinobu Tawada; Yoshihiro Fukuda; Masayuki Nakano; Osamu Yokosuka
Journal:  Dig Dis Sci       Date:  2011-06-17       Impact factor: 3.199

3.  Autoimmune acute liver failure: an emerging etiology for intractable acute liver failure.

Authors:  Keiichi Fujiwara; Shin Yasui; Osamu Yokosuka
Journal:  Hepatol Int       Date:  2012-09-28       Impact factor: 6.047

Review 4.  Acute and acute severe (fulminant) autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-10-23       Impact factor: 3.199

5.  The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis.

Authors:  Guiqiang Wang; Atsushi Tanaka; Hong Zhao; Jidong Jia; Xiong Ma; Kenichi Harada; Fu-Sheng Wang; Lai Wei; Qixia Wang; Ying Sun; Yuan Hong; Huiying Rao; Cumali Efe; George Lau; Diana Payawal; Rino Gani; Keith Lindor; Wasim Jafri; Masao Omata; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2021-05-04       Impact factor: 6.047

6.  Establishment of rat liver cancer cell lines with different metastatic potential.

Authors:  Lei Song; Jian-Gang Zhang; Long Zheng; Xu Feng; Jie Hou; Huan-Ling Zhang; Shu-Feng Liu
Journal:  Sci Rep       Date:  2020-05-20       Impact factor: 4.379

7.  Clinical and Pathological Characteristics of Autoimmune Hepatitis with Acute Presentation.

Authors:  Yi Shen; Changli Lu; Ruoting Men; Jianping Liu; Tinghong Ye; Li Yang
Journal:  Can J Gastroenterol Hepatol       Date:  2018-03-18

8.  Keratin 7 expression in hepatic cholestatic diseases.

Authors:  S Sakellariou; C Michaelides; T Voulgaris; J Vlachogiannakos; E Manesis; D G Tiniakos; I Delladetsima
Journal:  Virchows Arch       Date:  2021-07-27       Impact factor: 4.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.